Radiant Biotherapeutics
Toronto
About Radiant Biotherapeutics
Radiant Biotherapeutics is a revolutionary antibody platform company leading the new frontier of multi-valent, multi-specific therapeutics to deliver transformative therapies for patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $45.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2024)
- Website: radiantbio.com
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/radiant-biotherapeutics-97783 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.